Bioequivalence and Bioavailability Forum

Thair Saleh ☆ Jordan, 2024-07-01 11:42 (713 d 15:15 ago) Posting: # 24050 Views: 2,665	back conversion test [Regulatives / Guidelines] Post reply
	dear Colleagues in the case of metabolites, (unstable N-oxides or glucuronide metabolites, lactone-ring structures) found in the drug should always covered by the back conversion test, or there is a limit (2%, 5%, 10%) of the drug if the metabolite exceeds then should be covered.

Activity

Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
127 visitors (0 registered, 127 guests [including 38 identified bots]).
Forum time: 02:57 CEST (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another. Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz

back conversion test [Regulatives / Guidelines]